Circulating, Cell-Free DNA for Monitoring Player Load in Professional Football

被引:11
作者
Haller, Nils [1 ]
Ehlert, Tobias [1 ]
Schmidt, Sebastian [1 ]
Ochmann, David [1 ]
Sterzing, Bjoern [1 ]
Grus, Franz [2 ]
Simon, Perikles [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, Mainz, Germany
[2] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany
关键词
plasma DNA; overtraining; biomarker; player monitoring; soccer; FREE PLASMA DNA; MUSCLE DAMAGE; TRAINING LOAD; PERFORMANCE RESPONSES; TIME-COURSE; SOCCER; EXERCISE; INFLAMMATION; MARKER; INTENSITY;
D O I
10.1123/ijspp.2018-0756
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Purpose: Player monitoring in elite sport settings is becoming increasingly important. Questionnaire-based methods and bio-markers such as circulating, cell-free DNA (cfDNA) are suggested for load monitoring. cfDNA concentrations were shown to increase depending on total distance covered in football and were associated with overtraining in weight lifters. Thus, the objective of this study was to examine whether cfDNA is feasible as a monitoring tool in elite football players. Methods: Capillary blood samples from 22 male elite football players were collected over 4 mo of a regular season. Sampling was conducted the day before, 1 day after, or several days after regular-season games and/or training. In addition, each player filled in a visual analogue scale (VAS) questionnaire including the items "general perceived exertion," "muscular fatigue," and "mental fatigue." Performance during training and games was tracked by the Catapult system and with the OPTA system, respectively. Results: cfDNA values were significantly elevated in players the day after regular-season games (1.4-fold; P = .0004) in line with the scores of the VAS. Both parameters showed significantly higher values during midweek-game weeks. cfDNA concentrations correlated with training data, and VAS was correlated with the tracking of the season games. However, cfDNA and VAS did not correlate with each other. Conclusions: cfDNA concentrations at rest and VAS scores are influenced by previous load in professional football players. Future studies will reveal whether cfDNA might serve as a practically applicable marker for player load in football players.
引用
收藏
页码:718 / 726
页数:9
相关论文
共 50 条
  • [41] Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma
    Chen, Ken
    Zhang, Hong
    Zhang, Li-Na
    Ju, Shao-Qing
    Qi, Jing
    Huang, Dong-Feng
    Li, Feng
    Wei, Qun
    Zhang, Jing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (20) : 3143 - 3149
  • [42] Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia
    Lazar, Levente
    Rigo, Janos, Jr.
    Nagy, Balint
    Balogh, Krisztian
    Mako, Veronika
    Cervenak, Laszlo
    Mezes, Miklos
    Prohaszka, Zoltan
    Molvarec, Attila
    BMC MEDICAL GENETICS, 2009, 10
  • [43] Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Fotiou, Despoina
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11) : E905 - E909
  • [44] KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control study
    Le Calvez-Kelm, Florence
    Foll, Matthieu
    Wozniak, Magdalena B.
    Delhomme, Tiffany M.
    Durand, Geoffroy
    Chopard, Priscilia
    Pertesi, Maroulio
    Fabianova, Eleonora
    Adamcakova, Zora
    Holcatova, Ivana
    Foretova, Lenka
    Janout, Vladimir
    Vallee, Maxime P.
    Rinaldi, Sabina
    Brennan, Paul
    Mckay, James D.
    Byrnes, Graham B.
    Scelo, Ghislaine
    ONCOTARGET, 2016, 7 (48) : 78827 - 78840
  • [45] Computational Modeling for Circulating Cell-Free DNA in Clinical Oncology
    Phuong, Linh Nguyen
    Salas, Sebastien
    Benzekry, Sebastien
    JCO CLINICAL CANCER INFORMATICS, 2025, 9 : e2400224
  • [46] Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
    Vymetalkova, Veronika
    Cervena, Klara
    Bartu, Linda
    Vodicka, Pavel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [47] Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA
    Lehmann-Werman, Roni
    Magenheim, Judith
    Moss, Joshua
    Neiman, Daniel
    Abraham, Ofri
    Piyanzin, Sheina
    Zemmour, Hai
    Fox, Ilana
    Dor, Talya
    Grompe, Markus
    Landesberg, Giora
    Loza, Bao-Li
    Shaked, Abraham
    Olthoff, Kim
    Glaser, Benjamin
    Shemer, Ruth
    Dor, Yuval
    JCI INSIGHT, 2018, 3 (12):
  • [48] Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment
    Lowes, Hannah
    Pyle, Angela
    Santibanez-Koref, Mauro
    Hudson, Gavin
    MOLECULAR NEURODEGENERATION, 2020, 15 (01)
  • [49] Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
    Hao, T. B.
    Shi, W.
    Shen, X. J.
    Qi, J.
    Wu, X. H.
    Wu, Y.
    Tang, Y. Y.
    Ju, S. Q.
    BRITISH JOURNAL OF CANCER, 2014, 111 (08) : 1482 - 1489
  • [50] Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy
    Cheng, Chao
    Omura-Minamisawa, Motoko
    Kang, Yun
    Hara, Takamitsu
    Koike, Izumi
    Inoue, Tomio
    CANCER SCIENCE, 2009, 100 (02): : 303 - 309